Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma

Mao,Zhong‑Ping; Zhao,Li‑Jun; Zhou,Shui‑Hong; Liu,Meng‑Qin; Tan,Wei‑Feng; Yao,Hong‑Tian

doi:10.3892/ol.2014.2752

February-2015 Volume 9 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2015 Volume 9 Issue 2

Full Size Image

Article

Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma

Authors:
- Zhong‑Ping Mao
- Li‑Jun Zhao
- Shui‑Hong Zhou
- Meng‑Qin Liu
- Wei‑Feng Tan
- Hong‑Tian Yao
View Affiliations / Copyright

Affiliations: Department of Otolaryngology, The Second Hospital of Shaoxing City, Shaoxing, Zhejiang 312000, P.R. China, Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Pathology, The Second Hospital of Shaoxing City, Shaoxing, Zhejiang 312000, P.R. China, Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
Pages: 806-810
|
Published online on: December 1, 2014

https://doi.org/10.3892/ol.2014.2752
Expand metrics +

Abstract

Increasing glucose transporter‑1 (GLUT‑1) activity is one of the most important ways to increase the cellular influx of glucose. We previously demonstrated that increased GLUT‑1 expression was an independent predictor of survival in patients with laryngeal carcinoma. Thus, GLUT‑1 may present a novel therapeutic target in laryngeal carcinoma. In this study, the expression of GLUT‑1, P‑glycoprotein (P‑gp), multidrug resistance‑associated protein 1 (MRP1) and glutathione S‑transferase‑π (GST‑π) in laryngeal carcinomas was investigated by immunohistochemistry. Additionally, possible correlations between GLUT‑1 and P‑gp, MRP1 and GST‑π and various clinicopathological parameters were analyzed. In this study, 52.9% (18/34), 58.8% (20/34), 20.6% (7/34) and 58.8% (20/34) of the laryngeal carcinomas were positive for GLUT‑1, P‑gp, MRP1 and GST‑π, respectively. The expression of GLUT‑1, P‑gp, MRP1 and GST‑π was higher in laryngeal carcinoma specimens when compared with laryngeal precancerous lesions (P<0.05). Pearson's correlation analysis showed correlations between GLUT‑1 and P‑gp (r=0.364; P=0.034), GLUT‑1 and MRP1 (r=0.359; P=0.037) and P‑gp and GST‑π (r=0.426; P=0.012). GLUT‑1 expression was found to significantly correlate with tumor‑node‑metastasis classification (P=0.02) and clinical stage (P=0.037). Furthermore, P‑gp was found to significantly correlate with clinical stage (P=0.026). Univariate analysis showed that MRP1 expression was significantly associated with poor survival (c2=5.16; P=0.023). Multivariate analysis revealed that lymph node metastasis (P=0.009) and MRP1 overexpression (P=0.023) were significant predictors of poor survival. In the present study, the expression of GLUT‑1, P‑gp, MRP1 and GST‑π in laryngeal carcinomas was investigated, as well as the correlations between these proteins. P‑gp was found to significantly correlate with clinical stage, while MRP1 overexpression was significantly associated with poor survival.

View Figures

View References

1	Pérez-Sayáns M, Supuran CT, Pastorekova S, et al: The role of carbonic anhydrase IX in hypoxia control in OSCC. J Oral Pathol Med. 42:1–8. 2013. View Article : Google Scholar
2	Hong B, Lui VW, Hashiguchi M, Hui EP and Chan AT: Targeting tumor hypoxia in nasopharyngeal carcinoma. Head Neck. 35:133–145. 2013. View Article : Google Scholar
3	Gu J, Yamamoto H, Fukunaga H, et al: Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci. 51:2198–2205. 2006. View Article : Google Scholar : PubMed/NCBI
4	Wu XH, Chen SP, Mao JY, Ji XX, Yao HT and Zhou SH: Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma. Oncol Lett. 5:261–266. 2013.
5	Xu YY, Bao YY, Zhou SH and Fan J: Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1. Arch Med Res. 43:395–401. 2012. View Article : Google Scholar : PubMed/NCBI
6	Zhou SH, Fan J, Chen XM, Cheng KJ and Wang SQ: Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1. Head Neck. 31:1624–1633. 2009. View Article : Google Scholar : PubMed/NCBI
7	Shimanishi M, Ogi K, Sogabe Y, et al: Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia. J Oral Pathol Med. 42:382–388. 2013. View Article : Google Scholar
8	Chiba I, Ogawa K, Morioka T, et al: Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Oncol Lett. 2:21–28. 2011.PubMed/NCBI
9	Brophy S, Sheehan KM, McNamara DA, Deasy J, Bouchier-Hayes DJ and Kay EW: GLUT-1 expression and response to chemoradiotherapy in rectal cancer. Int J Cancer. 125:2778–2782. 2009. View Article : Google Scholar : PubMed/NCBI
10	Cantuaria G, Fagotti A, Ferrandina G, et al: GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer. 92:1144–1150. 2001. View Article : Google Scholar : PubMed/NCBI
11	Yu Z, Peng S, Hong-Ming P and Kai-Feng W: Expression of multi-drug resistance-related genes MDR3 and MRP as prognostic factors in clinical liver cancer patients. Hepatogastroenterology. 59:1556–1559. 2012.PubMed/NCBI
12	Wang J, Zhang J, Zhang L, et al: Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. Oncol Rep. 26:1081–1089. 2011.PubMed/NCBI
13	Calatozzolo C, Gelati M, Ciusani E, et al: Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol. 74:113–121. 2005. View Article : Google Scholar : PubMed/NCBI
14	Wang BL, Zhai HY, Chen BY, et al: Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary Pancreat Dis Int. 3:296–299. 2004.PubMed/NCBI
15	Min L, Chen Q, He S, Liu S and Ma Y: Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression. Mol Med Rep. 5:228–232. 2012.
16	Lelong-Rebel I, Brisson C, Fabre M, Bergerat JP and Rebel G: Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Anticancer Res. 28:55–68. 2008.PubMed/NCBI
17	Sobin LH, Gospodarowicz MK and Wittekind C: TNM Classification of Malignant Tumors. 7th ed. Oxford: Wiley-Blackwell; pp. 3362010
18	Camenzind RS, Chip S, Gutmann H, Kapfhammer JP, Nitsch C and Bendfeldt K: Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporters in a cortical slice culture model of the blood-brain barrier. Neuroscience. 170:361–371. 2010. View Article : Google Scholar : PubMed/NCBI
19	Bourasset F, Cisternino S, Temsamani J and Scherrmann JM: Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J Neurochem. 86:1564–1567. 2003. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles